Physician profile
John W Perry
NPI 1275596470
$1,382.43
in general payments reported to CMS, 2019-2025
27 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $93.76 · 2021: $247 · 2022: $94.95 · 2023: $257 · 2024: $226 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $360.88 | 2023-2025 | Icefx Cryoablation System |
| Atricure, INC. | $144.26 | 2021-2022 | |
| Terumo Medical Corporation | $104.92 | 2019 | |
| Vascular Graft Solutions INC | $88.90 | 2024 | Viola |
| Abiomed | $78.81 | 2023 | Impella |
| Cordis US Corp. | $67.01 | 2021 | |
| Medtronic, INC. | $59.24 | 2021-2022 | |
| Clearflow INC. | $53.48 | 2023 | Pleuraflow System With Flowglide |
| Peerless Surgical INC. | $49.49 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.70 | 2019-2021 | |
| Amarin Pharma, INC. | $35.90 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.34 | 2019 | |
| Abbott Laboratories | $29.94 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.43 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.17 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $21.96 | 2022 | |
| Artivion, INC. | $20.84 | 2019 | |
| Ethicon US, LLC | $18.80 | 2021 | |
| Bard Peripheral Vascular, INC. | $17.33 | 2020 | |
| Lundbeck LLC | $16.54 | 2019 | |
| Stryker Corporation | $14.42 | 2024 | Na |
| E.R. Squibb & Sons, L.L.C. | $14.09 | 2022 | |
| Lilly USA, LLC | $13.77 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.89 | 2020 | |
| Lsi Solutions INC | $12.75 | 2019 | |
| Allergan, INC. | $12.68 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.